Univ. of Texas SW Medical Center
Recent findings in breast implants described
Published in Drug Law Weekly, February 8th, 2005
Study 1: A scientist reports 'out points' criteria for breast implant removal without replacement and criteria to minimize reoperations following breast augmentation in a recent issue of Plastic and Reconstructive Surgery.
"Breast augmentation is a totally elective, medically unnecessary procedure, and surgeons and patients must prioritize minimizing tradeoffs, costs, and risks at the primary operation and at reoperations. At the U.S. Food and Drug Administration's advisory panel hearings in October of 2003 to consider approval of conventional silicone gel...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2005-02-08)
More Articles from Drug Law Weekly
- Abbott Laboratories
Indiana Circuit Court denies class certification in OxyContin litigation - Beckman Coulter, Inc.
Exclusive license agreement signed for intellectual property - BioVeris Corporation
Agreements completed with Children's Hospital & Research Center at Oakland - Biophan Technologies, Inc.
Biomedical technology firm executes letter of intent to acquire MRI company - Biophan Technologies, Inc.
Company's biomedical intellectual property portfolio crosses 100-patent mark - Bruckner Group
Biotechnology drug revenues will be hard hit by strict benefit management - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
